Re: Model building
Thanks Joachim, that is what I thought. I wanted to be sure that I invest
time building the right model and not just some model which works
(converges) but is biased.
Neil
Quoted reply history
On Fri, Dec 4, 2009 at 3:31 AM, Grevel, Joachim <
[email protected]> wrote:
> Hi Neil,
>
>
>
> You ask:
>
>
>
> “So my question is whether the fits, RES, WRES plots and the ofv values
> have meaning even when the minimization terminates”
>
>
>
> The answer: you bet they matter! Residual plots are the most informative
> output NONMEM gives you. They should guide you when you determine the basic
> structure of your model that is supported by the data. Successful
> termination, covariance step, standard errors, Eigen values, messages,
> warnings... are just icing on the cake vis-a-vis the residual plots.
>
>
>
> These are my two pennies worth of advice,
>
>
>
> Joachim
>
>
>
>
>
> *Joachim Grevel *
>
> Senior Pharmacometrician
>
> _____________________________________________________________________
>
> *AstraZeneca R&D Charnwood*
>
> Clinical Pharmacology & DMPK, Charnwood
>
> Bakewell Road, Loughborough, Leics., LE11 5RH, England
>
> Tel +44 (0) 1509 644035 Fax +44 (0) 1509 645576 Mobile +44 (0) 7920
> 285905
>
> *[email protected]*
>
> * *
>
> P Please consider the environment before printing this e-mail
>
>
>
>
>
>
>
> ------------------------------
>
> AstraZeneca UK Limited is a company incorporated in England and Wales with
> registered number: 03674842 and a registered office at 15 Stanhope Gate,
> London W1K 1LN.
>
> *Confidentiality Notice: *This message is private and may contain
> confidential, proprietary and legally privileged information. If you have
> received this message in error, please notify us and remove it from your
> system and note that you must not copy, distribute or take any action in
> reliance on it. Any unauthorised use or disclosure of the contents of this
> message is not permitted and may be unlawful.
>
> *Disclaimer:* Email messages may be subject to delays, interception,
> non-delivery and unauthorised alterations. Therefore, information expressed
> in this message is not given or endorsed by AstraZeneca UK Limited unless
> otherwise notified by an authorised representative independent of this
> message. No contractual relationship is created by this message by any
> person unless specifically indicated by agreement in writing other than
> email.
>
> *Monitoring: *AstraZeneca UK Limited may monitor email traffic data and
> content for the purposes of the prevention and detection of crime, ensuring
> the security of our computer systems and checking compliance with our Code
> of Conduct and policies.
>
> *From:* [email protected] [mailto:[email protected]]
> *On Behalf Of *Indranil Bhattacharya
> *Sent:* 03 December 2009 15:41
>
> *To:* [email protected]
> *Subject:* [NMusers] Model building
>
>
>
> Hi, I am in the process of developing a PK/PD model and have a naive
> question regarding model building.
>
> I currently do not have all the PD data and more data would be available in
> the future. For the current data set, I have tried models say A to D.
>
> Now model A (cell kill) and B (cell kill +transduction) converges using
> FOCE (no CV% but I am willing to live with that) but from the RES and WRES
> plots we can clearly see that there is some bias. The fit is OK but not
> great. The ofv values are around 400.
>
> Now models B (cell cycle specific kill), C (cell + precursor cell kill
> +transduction) and D (cell cycle specific + indirect response model) do not
> converge using FO or FOCE methods but when I look at the fits from the
> terminated runs, the fits are much better than those obtained with Model A,
> and there seems very little bias. Also the ofv values are between 160-250.
>
>
>
> So my question is whether the fits, RES, WRES plots and the ofv values have
> meaning even when the minimization terminates.
>
>
>
> Regards
>
>
>
> Neil
>
> --
> Indranil Bhattacharya
>
>
--
Indranil Bhattacharya